Streetbeat News

Products Services

AMGN

Deep-pocketed investors have shown a bullish sentiment towards Amgen (NASDAQ:AMGN), with options trading data from Benzinga indicating a significant interest in the stock. The data reveals a majority of investors leaning bullish, with notable options activities including both calls and puts, suggesting expectations of Amgen's stock price movement within a $240.0 to $320.0 range. Amgen, a leader in biotechnology-based human therapeutics, has seen its stock price slightly down at $285.91, with an RSI indicating it may be approaching overbought territory. The next earnings report is expected in 28 days.

Portfolio Pulse from Benzinga Insights

March 28, 2024 | 4:03 pm

ALDX

Aldeyra Therapeutics' stock is trading higher following the announcement of a clinical development plan for reproxalap in dry eye disease, aimed at enabling the resubmission of a New Drug Application.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 4:02 pm

UPS

UPS (NYSE:UPS) outlined an ambitious growth strategy at its 2024 Investor and Analyst Day, targeting $108 to $114 billion in revenue by 2026. The plan includes a focus on high-margin segments, technological investments, and operational efficiency improvements. Despite expecting a challenging first half of 2024, UPS aims for a consolidated operating margin of 13% by 2026. The company also highlighted its commitment to sustainability, diversity, and employee satisfaction.

Portfolio Pulse from Tornado

March 28, 2024 | 4:01 pm

At the BofA Securities 2024 Automotive Summit, General Motors CFO Paul Jacobson discussed GM's progress in EV production and capital allocation. GM is on track to meet its 2024 EV production goal, with the Cadillac LYRIQ setting monthly sales records. The company aims for EV profitability by 2025 and has initiated a $10 billion share repurchase program. Jacobson also highlighted a $2 billion cost reduction program and the strategic review of Cruise, GM's autonomous vehicle technology.

Portfolio Pulse from Tornado

March 28, 2024 | 3:58 pm

AAPL

AMZN

GLD

GOOG

META

MSFT

NVDA

QQQ

SPY

TSLA

USO

Nvidia (NVDA) has fallen below its trendline, indicating potential negative implications for NVDA and tech stocks. Fed's Christopher Waller suggests interest rates will remain unchanged due to disappointing inflation data. Early trade money flows show positive trends for AMZN and GOOG, neutral for MSFT and META, and negative for NVDA, AAPL, and TSLA. Mixed flows are observed in SPY and QQQ ETFs. Gold, represented by GLD, hits a new high with positive momo crowd buying, while oil, represented by USO, also sees buying. Bitcoin surpasses $70,000.

Portfolio Pulse from The Arora Report

March 28, 2024 | 3:55 pm

TSLA

Elon Musk, CEO of Tesla and SpaceX, has shifted his stance on digital super-intelligence, suggesting a more optimistic outlook. At the Abundance Summit 2024, Musk estimated a 10-20% chance that super-intelligence could end humanity but emphasized a probable future of abundance as the most likely outcome. This marks a departure from his previous warnings about the dangers of AI, including a call for a pause on AI development exceeding OpenAI's GPT-4 in 2023.

Portfolio Pulse from Ananya Gairola

March 28, 2024 | 3:49 pm

IMRX

Immuneering's stock price increased following the announcement that the first patient has been dosed in its Phase 1/2a trial of IMM-6-415, aimed at treating advanced solid tumors with RAF or RAS mutations.

Portfolio Pulse from Benzinga Newsdesk

March 28, 2024 | 3:45 pm

DOGE-USD

Dogecoin (DOGE) experienced a 15% rally in the past 24 hours, with a 40% increase in weekly gains, attributed to a surge in whale transactions and daily active addresses. Dogecoin20, an Ethereum-based derivative, raised $10 million in its presale. Large transaction volumes for Dogecoin rose by 92.8%, reaching $5.29 billion, and daily active addresses increased by 13.5%, totaling 199,190. A significant transfer of 250 million DOGE to Robinhood was reported. Optimism is high in the Dogecoin community, partly due to Elon Musk's payment company obtaining more licenses. Dogecoin's market cap surpassed $30 billion, with predictions of its price reaching between $0.465 to $1.

Portfolio Pulse from Khyathi Dalal

March 28, 2024 | 3:31 pm

TLRY

The cannabis sector is experiencing a resurgence due to Germany's partial legalization and potential U.S. rescheduling. Tim Seymour highlighted Tilray Brands, Inc. (TLRY) as well-positioned in Europe, especially in Germany, due to prior investments. The sector's growth is anticipated to continue with increased sales, revenue, and efficiency improvements.

Portfolio Pulse from Erica Kollmann

March 28, 2024 | 3:09 pm

SMMT

Akeso Inc. reported a significant profit of 1.94 billion yuan for 2023, driven by a surge in licensing income and product sales. The company's partnership with Summit Therapeutics contributed significantly to its revenue. Akeso's rights issue aims to raise funds for further R&D, leveraging its positive earnings. The company's flagship product, cadonilimab, and its next anticipated drug, ivonescimab, are key to its future growth. Despite a high P/E ratio, analysts are optimistic about Akeso's earnings outlook.

Portfolio Pulse from The Bamboo Works

March 28, 2024 | 2:58 pm